BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023

  Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that the Company intends to release its first quarter 2023 financial results on Monday, May 15, 2023.

  May 4, 2023

   · 

  3 min read
• Pharm Country

  SIGA Reports Financial Results for Three Months Ended March 31, 2023

  SIGA Technologies, Inc., a commercial-stage pharmaceutical company, reported financial results for the three months ended March 31, 2023.

  May 4, 2023

   · 

  10 min read
• Business

  Assembly Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights

  Assembly Biosciences, Inc., a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, reported financial results and recent highlights for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  8 min read
• BioCapital

  Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference

  Acumen Pharmaceuticals, Inc. announced that management will participate in a fireside chat at the 2023 Bank of America Healthcare Conference on Thursday, May 11, 2023 at 8:00 a.m. PT.

  May 4, 2023

   · 

  1 min read
• Business

  Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates

  Avalo Therapeutics, Inc., announced business updates and financial results for the first quarter of 2023.

  May 4, 2023

   · 

  9 min read
• Business

  Codexis Reports First Quarter 2023 Financial Results

  Codexis, Inc., a leading enzyme engineering company, announced financial results for the first quarter ended March 31, 2023, and provided a business update.

  May 4, 2023

   · 

  13 min read
• Business

  Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

  Eledon Pharmaceuticals, Inc. announced that it plans to release financial results for the first quarter ended March 31, 2023 on Thursday, May 11, after the close of trading.

  May 4, 2023

   · 

  1 min read
• Business

  NextCure Provides Business Update and Reports First Quarter 2023 Financial Results

  NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases provided a business update and reported first quarter 2023 financial results.

  May 4, 2023

   · 

  5 min read
• Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

  Galmed Pharmaceuticals Ltd. reported the execution of a definitive agreement for a $3M equity investment in OnKai Inc., leading an investment round of $6M.

  May 4, 2023

   · 

  7 min read
• Business

  Travere Therapeutics Reports First Quarter 2023 Financial Results

  Travere Therapeutics, Inc. reported its first quarter 2023 financial results and provided a corporate update.

  May 4, 2023

   · 

  24 min read